EGFR and lung carcinoma: Together, our findings indicate that HPV oncoproteins might change the behavior of lung cancer cells through changes in EGFR nuclear trafficking, and the expression of HPV 16E6/18E6 and EGFR serves as a predictive biomarker of survival benefits in lung adenocarcinoma patients.